The outlook revision reflects Moody’s expectation that Summa’s 2018 operating improvement will be sustainable and volumes will continue to return as the system refocuses on growth strategies.
Moody’s also acknowledged that cuts in government reimbursement, along with operating costs associated with a new patient tower, will challenge the system’s margins in 2019.
More articles on healthcare finance:
Blockchain: 4 use cases that show its value in healthcare
Arkansas medical center’s layoffs based on bad financial info, report claims
Texas Health Resources’ net income drops 45% in first nine months of 2018
